SlideShare a Scribd company logo
1 of 1
The Role of Hematology in the Diagnosis of
Hemophilia A
Brianna McKenna and Kimberly Campbell | MLT-1042 Hematology l Terri Domenici | 11/05/2018
Hematology and Diagnosis
Hemophilia A can be inherited and in rare instances can be an
acquired clotting disorder. It causes the patient’s blood to not clot
properly. Hemophilia A can be seen as early as infancy. Symptoms
depend on the severity of the disorder, which ranges from mild to
moderate to severe. Mild Hemophilia A has 5-40% working clotting
factors in the blood, moderate has 1-5%, and severe has less then
1%. Hematology will perform a CBC on an automatic hematology
analyzer using an EDTA whole blood specimen. They will also
perform PT, aPTT, Fibrinogen, and clotting factor tests on a semi-
automated coagulation analyzer using 3.2% sodium citrate whole
blood specimen. An increased time in the aPTT test helps the doctor
diagnose Hemophilia A.
Pathophysiology
Hemophilia A is an X-linked recessive gene mutation resulting in a
factor VIII deficiency. This disorder prevents the blood from clotting
properly, which can lead to prolonged bleeding. The deficiency stops
the clotting cascade before a clot can form.
• Organs and systems affected: muscles, joints, kidneys, the GI
tract, and the brain
• Effects: Acute pain, swelling, restriction on movements, arthritis,
blood in urine, black and bloody stool, changes in mental status,
seizures
• Population at risk: More common in men than women
Required Specimen
• Proper collection procedure: Venipuncture
• Proper specimen container or tube: EDTA whole blood tube and
3.2% sodium citrate whole blood tube
Instrument Methodology
Specimen Analysis Procedure
Diagnostic Results
• Automated CBC: Is normal unless the patient has heavy bleeding
or had bled for a long period of time. If there is heavy blood loss
the hematocrit, hemoglobin, and red blood cell count can be low
• Activated Partial Thromboplastin Time (APTT) Test: The time will
be longer with patients with hemophilia A because factor VIII is
measured here.
• Prothrombin Time (PT) Test: Normal
Interfering Substances
Smear Review
This would be a smear of a patient that had/has heavy bleeding or
has experienced prolong bleeding. The normal smear will be
normochromic/normocytic. A smear with blood loss is hypochromic.
References
Hemophilia. (2011, September 13). Retrieved from
https://www.cdc.gov/ncbddd/hemophilia/diagnosis.html
Hemophilia A. (n.d.). Retrieved from https://rarediseases.org/rare-
diseases/hemophilia-a/
Kamal, A. H., Tefferi, A., & Pruthi, R. K. (2007). How to Interpret and
Pursue an Abnormal Prothrombin Time, Activated Partial
Thromboplastin Time, and Bleeding Time in Adults. Mayo Clinic
Proceedings,82(7), 864-873. doi:10.4065/82.7.864
Klatt, E. C. (n.d.). CBC. Retrieved from
https://library.med.utah.edu/WebPath/HEMEHTML/HEME024.html
Magazine, L. (2018, May 17). Haemophilia: What To Eat And What
To Avoid. Retrieved from https://www.longevitylive.com/anti-aging-
beauty/haemophilia-eat-avoid-nutrition-bleed/
Pippard, M. J. (2017). Microcytic anaemias in childhood and iron-
refractory iron deficiency anaemia. British Journal of
Haematology,177(2), 167-168. doi:10.1111/bjh.14558
Preanalytical: Specimen is checked for label and correct volume along
with looking for clotting. Whole blood is used. The barcode or patient
info is scanned or manually entered into the system.
Analytical: Patient specimen in an EDTA tube is loaded into an
analyzer such as the Sysmex XN 550 to obtain a CBC. The plasma
from a sodium citrate tube is loaded in a KC1 Delta to get the APTT
results. If there is heavy blood loss with a low hematocrit and an
abnormal CBC, then a smear review is required.
Post Analytical: Abnormal CBC results are flagged in the computer
and printout. The APTT must be reviewed and determined if normal or
abnormal. The smear is reviewed for abnormal morphology and
manually entered into the LIS.
• The fasting state of the patient can affect
plasma turbidity. This can interfere with PT
and aPPT optical systems and cause false
results.
• Time between collection and testing can
interfere with results. Waiting more than 4
hours after collection to perform an aPTT
can cause inaccurate results.
• A high hematocrit can interfere with results
due to the ratio of plasma to anticoagulant
being altered.
KC1 Delta is one of many semi-
automatic coagulation instruments
used to detect clots. The time
required for plasma to clot is
recorded.
This is used to determine
concentration of clotting factors.
prothrombin times (PT), Activation
partial thromboplastic times
(aPTT), and fibrinogen
SysmexXN-550 is one example
of an automated hematology
analyzer used to obtain a CBC
on a patient.

More Related Content

What's hot (20)

Antibody Diversity-Gene Rearrangement
Antibody Diversity-Gene RearrangementAntibody Diversity-Gene Rearrangement
Antibody Diversity-Gene Rearrangement
 
Humoral immune response
Humoral immune responseHumoral immune response
Humoral immune response
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Graft versus Tumour effect
Graft versus Tumour effectGraft versus Tumour effect
Graft versus Tumour effect
 
G6PD Deficiency Anaemai
G6PD Deficiency AnaemaiG6PD Deficiency Anaemai
G6PD Deficiency Anaemai
 
T cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiationT cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiation
 
Haemoglobinopathies
HaemoglobinopathiesHaemoglobinopathies
Haemoglobinopathies
 
Transplant rejection
Transplant rejectionTransplant rejection
Transplant rejection
 
2. immune regulation
2. immune regulation2. immune regulation
2. immune regulation
 
Anemia
AnemiaAnemia
Anemia
 
B cell activations
B cell activationsB cell activations
B cell activations
 
Vaccine immunology
Vaccine immunologyVaccine immunology
Vaccine immunology
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Inborn error of metabolism
Inborn error of metabolismInborn error of metabolism
Inborn error of metabolism
 
polyclonal antibodies
polyclonal antibodiespolyclonal antibodies
polyclonal antibodies
 
7.Laboratory safety and Biohazard
7.Laboratory safety and Biohazard7.Laboratory safety and Biohazard
7.Laboratory safety and Biohazard
 
Radioreceptor assay
Radioreceptor assayRadioreceptor assay
Radioreceptor assay
 
Sickle cell anemia- An Overview
Sickle cell anemia- An OverviewSickle cell anemia- An Overview
Sickle cell anemia- An Overview
 
Sample collection and processig
Sample collection and processigSample collection and processig
Sample collection and processig
 
Warburg effect & cancer
Warburg effect & cancerWarburg effect & cancer
Warburg effect & cancer
 

Similar to Hematology Scientific Poster

Blood Banking Scientific Poster
Blood Banking Scientific PosterBlood Banking Scientific Poster
Blood Banking Scientific PosterKimberly Campbell
 
Management of health laboratory services
Management of health laboratory servicesManagement of health laboratory services
Management of health laboratory servicesAhmadAlnatour5
 
Management of health laboratory services
Management of health laboratory servicesManagement of health laboratory services
Management of health laboratory servicesAhmad Al Natour
 
Hema I Chapter 10_PCV.ppt
Hema I Chapter 10_PCV.pptHema I Chapter 10_PCV.ppt
Hema I Chapter 10_PCV.pptderibew genetu
 
Blood component transfusion in criticalcare now
Blood component transfusion in criticalcare nowBlood component transfusion in criticalcare now
Blood component transfusion in criticalcare nowMuhammad Akram
 
Blood conservation strategy
Blood conservation strategyBlood conservation strategy
Blood conservation strategyVinodh Natarajan
 
BloodTransfussionGuidelines.pdf
BloodTransfussionGuidelines.pdfBloodTransfussionGuidelines.pdf
BloodTransfussionGuidelines.pdfMerlitaHerbani1
 
Coagulation monitoring and teg
Coagulation monitoring and tegCoagulation monitoring and teg
Coagulation monitoring and tegIndia CTVS
 
New Microsoft Office PowerPoint Presentation.pptx
New Microsoft Office PowerPoint Presentation.pptxNew Microsoft Office PowerPoint Presentation.pptx
New Microsoft Office PowerPoint Presentation.pptxjyotikumari279462
 
7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.pptRyanJayAbolencia1
 
7.-Peter-Hudson-Blood-transfusion (1).ppt
7.-Peter-Hudson-Blood-transfusion (1).ppt7.-Peter-Hudson-Blood-transfusion (1).ppt
7.-Peter-Hudson-Blood-transfusion (1).pptLemmwellBryanAdante
 
7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.pptfarhanimlak
 
Clinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic ApheresisClinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic ApheresisRHMBONCO
 
1 general-approach-in-investigation-of-hemostasis1
1 general-approach-in-investigation-of-hemostasis11 general-approach-in-investigation-of-hemostasis1
1 general-approach-in-investigation-of-hemostasis1DuyenNguyen307
 
Coagulation profiles (pt,ptt,at, fib
Coagulation profiles (pt,ptt,at, fibCoagulation profiles (pt,ptt,at, fib
Coagulation profiles (pt,ptt,at, fibAKHTAR HUSSAIN
 
Biomedical Instrumentation
Biomedical InstrumentationBiomedical Instrumentation
Biomedical Instrumentationlinsstalex
 
investigations of bleeding disorder (1).pptx
investigations of bleeding disorder (1).pptxinvestigations of bleeding disorder (1).pptx
investigations of bleeding disorder (1).pptxRajeshSaiSajja
 

Similar to Hematology Scientific Poster (20)

Revised hemophilia
Revised hemophiliaRevised hemophilia
Revised hemophilia
 
Blood Banking Scientific Poster
Blood Banking Scientific PosterBlood Banking Scientific Poster
Blood Banking Scientific Poster
 
Rational use of blood
Rational use of bloodRational use of blood
Rational use of blood
 
Management of health laboratory services
Management of health laboratory servicesManagement of health laboratory services
Management of health laboratory services
 
Management of health laboratory services
Management of health laboratory servicesManagement of health laboratory services
Management of health laboratory services
 
Counting of rbc and wbc
Counting of rbc and wbcCounting of rbc and wbc
Counting of rbc and wbc
 
Hema I Chapter 10_PCV.ppt
Hema I Chapter 10_PCV.pptHema I Chapter 10_PCV.ppt
Hema I Chapter 10_PCV.ppt
 
Blood component transfusion in criticalcare now
Blood component transfusion in criticalcare nowBlood component transfusion in criticalcare now
Blood component transfusion in criticalcare now
 
Blood conservation strategy
Blood conservation strategyBlood conservation strategy
Blood conservation strategy
 
BloodTransfussionGuidelines.pdf
BloodTransfussionGuidelines.pdfBloodTransfussionGuidelines.pdf
BloodTransfussionGuidelines.pdf
 
Coagulation monitoring and teg
Coagulation monitoring and tegCoagulation monitoring and teg
Coagulation monitoring and teg
 
New Microsoft Office PowerPoint Presentation.pptx
New Microsoft Office PowerPoint Presentation.pptxNew Microsoft Office PowerPoint Presentation.pptx
New Microsoft Office PowerPoint Presentation.pptx
 
7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt
 
7.-Peter-Hudson-Blood-transfusion (1).ppt
7.-Peter-Hudson-Blood-transfusion (1).ppt7.-Peter-Hudson-Blood-transfusion (1).ppt
7.-Peter-Hudson-Blood-transfusion (1).ppt
 
7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt
 
Clinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic ApheresisClinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic Apheresis
 
1 general-approach-in-investigation-of-hemostasis1
1 general-approach-in-investigation-of-hemostasis11 general-approach-in-investigation-of-hemostasis1
1 general-approach-in-investigation-of-hemostasis1
 
Coagulation profiles (pt,ptt,at, fib
Coagulation profiles (pt,ptt,at, fibCoagulation profiles (pt,ptt,at, fib
Coagulation profiles (pt,ptt,at, fib
 
Biomedical Instrumentation
Biomedical InstrumentationBiomedical Instrumentation
Biomedical Instrumentation
 
investigations of bleeding disorder (1).pptx
investigations of bleeding disorder (1).pptxinvestigations of bleeding disorder (1).pptx
investigations of bleeding disorder (1).pptx
 

More from Kimberly Campbell

More from Kimberly Campbell (6)

Clinical Case study PowerPoint
Clinical Case study PowerPointClinical Case study PowerPoint
Clinical Case study PowerPoint
 
Nephelometry
NephelometryNephelometry
Nephelometry
 
Kimberly's Career map
Kimberly's Career mapKimberly's Career map
Kimberly's Career map
 
Career map
Career mapCareer map
Career map
 
Clinical Microbiology Scientific Poster
Clinical Microbiology Scientific PosterClinical Microbiology Scientific Poster
Clinical Microbiology Scientific Poster
 
UA pylonephritis project
UA pylonephritis projectUA pylonephritis project
UA pylonephritis project
 

Recently uploaded

Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 

Recently uploaded (20)

Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 

Hematology Scientific Poster

  • 1. The Role of Hematology in the Diagnosis of Hemophilia A Brianna McKenna and Kimberly Campbell | MLT-1042 Hematology l Terri Domenici | 11/05/2018 Hematology and Diagnosis Hemophilia A can be inherited and in rare instances can be an acquired clotting disorder. It causes the patient’s blood to not clot properly. Hemophilia A can be seen as early as infancy. Symptoms depend on the severity of the disorder, which ranges from mild to moderate to severe. Mild Hemophilia A has 5-40% working clotting factors in the blood, moderate has 1-5%, and severe has less then 1%. Hematology will perform a CBC on an automatic hematology analyzer using an EDTA whole blood specimen. They will also perform PT, aPTT, Fibrinogen, and clotting factor tests on a semi- automated coagulation analyzer using 3.2% sodium citrate whole blood specimen. An increased time in the aPTT test helps the doctor diagnose Hemophilia A. Pathophysiology Hemophilia A is an X-linked recessive gene mutation resulting in a factor VIII deficiency. This disorder prevents the blood from clotting properly, which can lead to prolonged bleeding. The deficiency stops the clotting cascade before a clot can form. • Organs and systems affected: muscles, joints, kidneys, the GI tract, and the brain • Effects: Acute pain, swelling, restriction on movements, arthritis, blood in urine, black and bloody stool, changes in mental status, seizures • Population at risk: More common in men than women Required Specimen • Proper collection procedure: Venipuncture • Proper specimen container or tube: EDTA whole blood tube and 3.2% sodium citrate whole blood tube Instrument Methodology Specimen Analysis Procedure Diagnostic Results • Automated CBC: Is normal unless the patient has heavy bleeding or had bled for a long period of time. If there is heavy blood loss the hematocrit, hemoglobin, and red blood cell count can be low • Activated Partial Thromboplastin Time (APTT) Test: The time will be longer with patients with hemophilia A because factor VIII is measured here. • Prothrombin Time (PT) Test: Normal Interfering Substances Smear Review This would be a smear of a patient that had/has heavy bleeding or has experienced prolong bleeding. The normal smear will be normochromic/normocytic. A smear with blood loss is hypochromic. References Hemophilia. (2011, September 13). Retrieved from https://www.cdc.gov/ncbddd/hemophilia/diagnosis.html Hemophilia A. (n.d.). Retrieved from https://rarediseases.org/rare- diseases/hemophilia-a/ Kamal, A. H., Tefferi, A., & Pruthi, R. K. (2007). How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults. Mayo Clinic Proceedings,82(7), 864-873. doi:10.4065/82.7.864 Klatt, E. C. (n.d.). CBC. Retrieved from https://library.med.utah.edu/WebPath/HEMEHTML/HEME024.html Magazine, L. (2018, May 17). Haemophilia: What To Eat And What To Avoid. Retrieved from https://www.longevitylive.com/anti-aging- beauty/haemophilia-eat-avoid-nutrition-bleed/ Pippard, M. J. (2017). Microcytic anaemias in childhood and iron- refractory iron deficiency anaemia. British Journal of Haematology,177(2), 167-168. doi:10.1111/bjh.14558 Preanalytical: Specimen is checked for label and correct volume along with looking for clotting. Whole blood is used. The barcode or patient info is scanned or manually entered into the system. Analytical: Patient specimen in an EDTA tube is loaded into an analyzer such as the Sysmex XN 550 to obtain a CBC. The plasma from a sodium citrate tube is loaded in a KC1 Delta to get the APTT results. If there is heavy blood loss with a low hematocrit and an abnormal CBC, then a smear review is required. Post Analytical: Abnormal CBC results are flagged in the computer and printout. The APTT must be reviewed and determined if normal or abnormal. The smear is reviewed for abnormal morphology and manually entered into the LIS. • The fasting state of the patient can affect plasma turbidity. This can interfere with PT and aPPT optical systems and cause false results. • Time between collection and testing can interfere with results. Waiting more than 4 hours after collection to perform an aPTT can cause inaccurate results. • A high hematocrit can interfere with results due to the ratio of plasma to anticoagulant being altered. KC1 Delta is one of many semi- automatic coagulation instruments used to detect clots. The time required for plasma to clot is recorded. This is used to determine concentration of clotting factors. prothrombin times (PT), Activation partial thromboplastic times (aPTT), and fibrinogen SysmexXN-550 is one example of an automated hematology analyzer used to obtain a CBC on a patient.